1.Self-Injurious Behavior Revealing Advanced Primary Progressive Multiple Sclerosis with a Massive Right Temporal Lesion.
Markus GSCHWIND ; Agustina Maria LASCANO ; Gürkan KAYA ; Frederic ASSAL
Journal of Clinical Neurology 2018;14(2):251-253
No abstract available.
Multiple Sclerosis, Chronic Progressive*
;
Self-Injurious Behavior*
2.Contingent Negative Variation Is Associated with Cognitive Dysfunction and Secondary Progressive Disease Course in Multiple Sclerosis.
Utku UYSAL ; Fethi IDIMAN ; Egemen IDIMAN ; Serkan OZAKBAS ; Sirel KARAKAS ; Jared BRUCE
Journal of Clinical Neurology 2014;10(4):296-303
BACKGROUND AND PURPOSE: The relationship between contingent negative variation (CNV), which is an event-related potential, and cognition in multiple sclerosis (MS) has not been examined previously. The primary objective of the present study was thus to determine the association between CNV and cognition in a sample of MS patients. METHODS: The subjects of this study comprised 66 MS patients [50 with relapsing-remitting MS (RRMS) and 16 with secondary progressive MS (SPMS)] and 40 matched healthy volunteers. A neuropsychological battery was administered to all of the subjects; CNV recordings were made from the Cz, Fz, and Pz electrodes, and the amplitude and area under the curve (AUC) were measured at each electrode. RESULTS: RRMS patients exhibited CNVs with lower amplitudes and smaller AUCs than the controls at Pz. SPMS patients exhibited CNVs with lower amplitudes and smaller AUCs than the controls, and CNVs with a smaller amplitude than the RRMS patients at both Cz and Pz. After correcting for multiple comparisons, a lower CNV amplitude at Pz was significantly associated with worse performance on measures of speed of information processing, verbal fluency, verbal learning, and verbal recall. CONCLUSIONS: CNV may serve as a marker for disease progression and cognitive dysfunction in MS. Further studies with larger samples and wider electrode coverage are required to fully assess the value of CNV in these areas.
Area Under Curve
;
Automatic Data Processing
;
Cognition
;
Contingent Negative Variation*
;
Disease Progression
;
Electrodes
;
Evoked Potentials
;
Healthy Volunteers
;
Humans
;
Multiple Sclerosis*
;
Multiple Sclerosis, Chronic Progressive
;
Multiple Sclerosis, Relapsing-Remitting
;
Neuropsychological Tests
;
Verbal Learning
3.Clinical Presentations and Phenotypic Spectrum of Multiple Sclerosis at a University Hospital in Saudi Arabia.
Saima NAZISH ; Rizwana SHAHID ; Azra ZAFAR ; Foziah ALSHAMRANI ; Abdullah Al SULAIMAN ; Majed ALABDALI ; Danah ALJAAFARI ; Esraa AL WABARI ; Fahd A ALKHAMIS
Journal of Clinical Neurology 2018;14(3):359-365
BACKGROUND AND PURPOSE: The objective of this study was to determine the frequencies of different clinical presentations and the phenotypic spectrum of multiple sclerosis (MS). METHODS: This cross-sectional study was performed in the Neurology Department of King Fahd Hospital of University Alkhobar in the Kingdom of Saudi Arabia (KSA). Data of 190 MS patients who fulfilled the McDonald criteria were retrieved from medical records and analyzed. RESULTS: The age at disease onset was 26.27±8.2 years (mean±SD) and disease duration was 6.38±5.10 years. The male-to-female ratio was 1:1.6. Optic neuritis and myelitis were the most-frequent first clinical presentations. Sensory (73.1%), motor (61%), and visual (58.4%) symptoms were the most-frequent established clinical symptoms. Relapsing-remitting multiple sclerosis (RRMS) was present in 75% of the cases. Supratentorial T2-weighted white-matter lesions and deep-gray-matter or juxtacortical lesions were the most-frequent magnetic resonance imaging (MRI) lesions, comprising 28% and 23.7% of all MRI lesions observed in 93.6% and 79.4% of the cases, respectively. The scores on the Expanded Disability Status Scale were within the range of 1.0–5.5 in 82.1% of the patients. There were 145 (76.3%) patients taking interferon β therapy. CONCLUSIONS: MS presenting in the hospital setting is more common in KSA than reported previously, and the number of diagnosed cases in increasing. It is therefore an emerging and disabling neurological illness in KSA with clinical characteristics not dissimilar to those in other middle eastern countries. A decrease in the frequency of patients with secondary progressive multiple sclerosis (SPMS) indicates either that more new cases of RRMS are being diagnosed or that adequate treatments of RRMS are preventing the evolution to SPMS. Further larger and population-wide epidemiological and clinical studies with the long-term follow-up of MS patients are required to better assess the clinical spectrum of MS in KSA.
Cross-Sectional Studies
;
Epidemiology
;
Follow-Up Studies
;
Humans
;
Interferons
;
Magnetic Resonance Imaging
;
Medical Records
;
Multiple Sclerosis*
;
Multiple Sclerosis, Chronic Progressive
;
Multiple Sclerosis, Relapsing-Remitting
;
Myelitis
;
Neurology
;
Optic Neuritis
;
Phenotype
;
Prevalence
;
Saudi Arabia*
4.Progressive Weakness, Cognitive Dysfunction and Seizures.
Annals of the Academy of Medicine, Singapore 2016;45(7):330-331
Abducens Nerve Diseases
;
etiology
;
Brain
;
diagnostic imaging
;
Cognitive Dysfunction
;
etiology
;
Epilepsies, Partial
;
etiology
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Multiple Sclerosis, Chronic Progressive
;
cerebrospinal fluid
;
complications
;
diagnostic imaging
;
Muscle Weakness
;
etiology
;
Oligoclonal Bands
;
cerebrospinal fluid
;
Paresis
;
etiology
;
Paresthesia
;
etiology
;
Seizures
;
etiology